Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ONCO |
---|---|---|
09:32 ET | 7650 | 0.1491 |
09:36 ET | 600 | 0.1508 |
09:38 ET | 2900 | 0.1447 |
09:39 ET | 536 | 0.148 |
09:41 ET | 32100 | 0.156 |
09:43 ET | 1576 | 0.155 |
09:45 ET | 2550 | 0.1564 |
09:48 ET | 3300 | 0.1564 |
09:50 ET | 500 | 0.1521 |
09:52 ET | 78036 | 0.152 |
09:54 ET | 129 | 0.1541 |
09:56 ET | 1137 | 0.148 |
09:57 ET | 2280 | 0.1478 |
09:59 ET | 500 | 0.1478 |
10:01 ET | 49388 | 0.1372 |
10:03 ET | 14800 | 0.141007 |
10:06 ET | 1330 | 0.139 |
10:08 ET | 923 | 0.1393 |
10:10 ET | 1191 | 0.141 |
10:19 ET | 23500 | 0.1437 |
10:26 ET | 200 | 0.1437 |
10:28 ET | 5500 | 0.1401 |
10:32 ET | 24800 | 0.1441 |
10:33 ET | 54151 | 0.1421 |
10:35 ET | 2102 | 0.1421 |
10:39 ET | 7000 | 0.142201 |
10:48 ET | 500 | 0.1422 |
10:53 ET | 7298 | 0.1423 |
10:55 ET | 12200 | 0.1407 |
10:57 ET | 6117 | 0.1403 |
11:00 ET | 6983 | 0.1402 |
11:02 ET | 77200 | 0.1441 |
11:04 ET | 8104 | 0.147 |
11:06 ET | 546054 | 0.16 |
11:08 ET | 229531 | 0.1674 |
11:09 ET | 172590 | 0.1651 |
11:11 ET | 47219 | 0.1651 |
11:13 ET | 25888 | 0.16101 |
11:15 ET | 116294 | 0.1599 |
11:18 ET | 267195 | 0.1715 |
11:20 ET | 202576 | 0.185 |
11:22 ET | 1830609 | 0.22 |
11:24 ET | 2144127 | 0.2201 |
11:26 ET | 1603559 | 0.2294 |
11:27 ET | 2792019 | 0.258 |
11:29 ET | 2898171 | 0.25095 |
11:31 ET | 1760476 | 0.2501 |
11:33 ET | 1688727 | 0.26 |
11:36 ET | 1246813 | 0.24305 |
11:38 ET | 1385767 | 0.2361 |
11:40 ET | 1677190 | 0.213 |
11:42 ET | 899707 | 0.217 |
11:44 ET | 868090 | 0.2049 |
11:45 ET | 365354 | 0.2118 |
11:47 ET | 841243 | 0.1935 |
11:49 ET | 512388 | 0.196 |
11:51 ET | 480401 | 0.2006 |
11:54 ET | 183278 | 0.2001 |
11:56 ET | 257072 | 0.197799 |
11:58 ET | 259212 | 0.1922 |
12:00 ET | 162425 | 0.1979 |
12:02 ET | 108194 | 0.1911 |
12:03 ET | 152578 | 0.191 |
12:05 ET | 133289 | 0.1909 |
12:07 ET | 654772 | 0.1862 |
12:09 ET | 678288 | 0.1697 |
12:12 ET | 549359 | 0.17805 |
12:14 ET | 255189 | 0.1725 |
12:16 ET | 135467 | 0.1676 |
12:18 ET | 257558 | 0.1613 |
12:20 ET | 54767 | 0.167273 |
12:21 ET | 115656 | 0.1738 |
12:23 ET | 53597 | 0.1731 |
12:25 ET | 56715 | 0.168 |
12:27 ET | 158264 | 0.1635 |
12:30 ET | 45238 | 0.17 |
12:32 ET | 105250 | 0.164 |
12:34 ET | 200668 | 0.1639 |
12:36 ET | 42849 | 0.166 |
12:38 ET | 20026 | 0.1632 |
12:39 ET | 118066 | 0.167 |
12:41 ET | 154961 | 0.1766 |
12:43 ET | 426047 | 0.1727 |
12:45 ET | 10365 | 0.1747 |
12:48 ET | 26930 | 0.1722 |
12:50 ET | 66591 | 0.168 |
12:52 ET | 113686 | 0.1685 |
12:54 ET | 45709 | 0.1679 |
12:56 ET | 105807 | 0.163 |
12:57 ET | 32013 | 0.165 |
12:59 ET | 28806 | 0.166 |
01:01 ET | 56379 | 0.1701 |
01:03 ET | 214664 | 0.179 |
01:06 ET | 140911 | 0.1844 |
01:08 ET | 252661 | 0.1803 |
01:10 ET | 95365 | 0.174 |
01:12 ET | 31299 | 0.179 |
01:14 ET | 167018 | 0.1881 |
01:15 ET | 168396 | 0.1889 |
01:17 ET | 233640 | 0.1863 |
01:19 ET | 337232 | 0.1796 |
01:21 ET | 160032 | 0.1733 |
01:24 ET | 39648 | 0.1712 |
01:26 ET | 47403 | 0.175 |
01:28 ET | 128876 | 0.184 |
01:30 ET | 24987 | 0.1796 |
01:32 ET | 31073 | 0.184 |
01:33 ET | 4557 | 0.1795 |
01:35 ET | 3199 | 0.1789 |
01:37 ET | 22215 | 0.1755 |
01:39 ET | 4599 | 0.176 |
01:42 ET | 231148 | 0.1613 |
01:44 ET | 22202 | 0.16632 |
01:46 ET | 21920 | 0.166 |
01:48 ET | 63147 | 0.1744 |
01:50 ET | 52710 | 0.1754 |
01:51 ET | 39655 | 0.1767 |
01:53 ET | 70061 | 0.179599 |
01:55 ET | 26429 | 0.1781 |
01:57 ET | 16375 | 0.177987 |
02:00 ET | 60004 | 0.1766 |
02:02 ET | 11010 | 0.1758 |
02:04 ET | 87121 | 0.174 |
02:06 ET | 10257 | 0.1697 |
02:08 ET | 932 | 0.166 |
02:09 ET | 400 | 0.169438 |
02:11 ET | 39523 | 0.166 |
02:13 ET | 13407 | 0.1703 |
02:15 ET | 23886 | 0.17385 |
02:18 ET | 13907 | 0.1749 |
02:20 ET | 13622 | 0.1749 |
02:22 ET | 89694 | 0.1818 |
02:24 ET | 55454 | 0.1835 |
02:26 ET | 3464 | 0.1815 |
02:27 ET | 63852 | 0.18 |
02:29 ET | 30283 | 0.18 |
02:31 ET | 26581 | 0.1805 |
02:33 ET | 1700 | 0.1801 |
02:36 ET | 80141 | 0.1822 |
02:38 ET | 110969 | 0.1879 |
02:40 ET | 245002 | 0.189 |
02:42 ET | 49634 | 0.19 |
02:44 ET | 163948 | 0.184 |
02:45 ET | 62067 | 0.1863 |
02:47 ET | 202221 | 0.1969 |
02:49 ET | 106990 | 0.1959 |
02:51 ET | 182252 | 0.2 |
02:54 ET | 260516 | 0.1975 |
02:56 ET | 179542 | 0.18 |
02:58 ET | 137630 | 0.1771 |
03:00 ET | 20582 | 0.1801 |
03:02 ET | 17068 | 0.1798 |
03:03 ET | 12857 | 0.18 |
03:05 ET | 103604 | 0.177 |
03:07 ET | 13652 | 0.17685 |
03:09 ET | 38880 | 0.1765 |
03:12 ET | 30439 | 0.1833 |
03:14 ET | 50324 | 0.1769 |
03:16 ET | 160818 | 0.1702 |
03:18 ET | 17800 | 0.171 |
03:20 ET | 4542 | 0.175 |
03:21 ET | 57421 | 0.1701 |
03:23 ET | 25788 | 0.1703 |
03:25 ET | 660 | 0.1715 |
03:27 ET | 20874 | 0.1748 |
03:32 ET | 1101 | 0.1752 |
03:34 ET | 41152 | 0.1766 |
03:36 ET | 14732 | 0.1768 |
03:38 ET | 21115 | 0.1797 |
03:39 ET | 42290 | 0.1797 |
03:41 ET | 152793 | 0.1832 |
03:43 ET | 79259 | 0.18 |
03:45 ET | 62842 | 0.179 |
03:48 ET | 45103 | 0.178 |
03:50 ET | 24355 | 0.1767 |
03:52 ET | 12529 | 0.1774 |
03:54 ET | 16782 | 0.1816 |
03:56 ET | 31366 | 0.185 |
03:57 ET | 82034 | 0.1924 |
03:59 ET | 83094 | 0.1819 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Onconetix Inc | 4.1M | -0.1x | --- |
Kiromic Biopharma Inc | 4.1M | -0.1x | --- |
Alzamend Neuro Inc | 4.1M | -0.3x | --- |
Phio Pharmaceuticals Corp | 4.2M | -0.2x | --- |
Altamira Therapeutics Ltd | 4.0M | -0.1x | --- |
Neximmune Inc | 4.4M | -0.1x | --- |
Onconetix, Inc. is a commercial stage biotechnology company. It is focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. It has Entadfi, a Food and Drug Administration approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. Entadfi is a once-daily, oral treatment for BPH that combines finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. Proclarix is a next generation protein-based blood test that can be done with the same sample as a patient’s regular PSA test. Proteomedix is seeking to develop diagnostic, prognostic, and predictive tools to enable cancer management at all stages of disease progression.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1M |
---|---|
Revenue (TTM) | $758.9K |
Shares Outstanding | 22.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.41 |
Book Value | $2.63 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,897.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.